Introduction: The most common cause of tracheal stenosis (TS) continues to be traumas according to the intubation and tracheostomy. Bronchoscopy is considered the gold standard for the detection and diagnosis of tracheobronchial pathology. There are several treatment options. We aimed to discuss our tracheal stenosis patients' treatment options, and their follow-up period.
INtrODuCtION
Laryngotracheal stenosis (LTS) is a rare condition, which causes significant morbidity and can precipitate lifethreatening airway compromise. It can be caused by a variable pathologic processes, the most common being postintubation injury (1) . Postintubation tracheal stenosis (PITS) is occurs mainly after tracheostomy or longterm intubation. While granulation tissue formation due to intubation could occur within hours, tracheal stenosis usually takes more than five days to appear (2) . Intensive health care administrations has decreased its incidence over years. The reported incidence of tracheal stenosis after tracheostomy and prolonged intubation varies between 0.6% to 21% and 6% to 21%, respectively (3, 4) . In a study performed in London, the predictive rate of PITS was calculated as 926 new cases per one year. The incidence may differ in various countries. The high incidence could be seen in the countries with high ICU bed occupancy and large population at risk.
The stenosis generally develops as a result of ischemic necrosis in the trachea secondary to the endo-tracheal tube overinflation or to the tracheostomy cuff. While same mechanism of action can cause posttracheostomy tracheal stenosis (PTTS); destruction of cartilaginous support after tracheal ring fractures during tracheostomy placaement may result in more complex ones.
Regarding the risk factors of PITS, some studies have demonstrated prolonged intubation (more than 24 hours), endotracheal tube material, over-inflation of its cuff, trauma during intubation and tube displacement after intubation (4) .
Unfortunately, because of the severity of symptoms, most of these patients undergo tracheostomy despite the fact that the main treatments for these patients are bronchoscopy and dilatation as well as airway resection and reconstruction at an appropriate time. Although there is various therapeutic options, end-toend anastomosis following tracheal resection is the treatment of choice for PITS.
In this study, we aimed to present our data of PITS/ PTTS developed cases and their management strategy according to the current literature. All data regarding their etiology, treatment choice, recurrence, and mortality are also discussed.
MAtErIALS and MEtHODS
After the approval of the Local Ethics Commitee, all consecutive referred patients with TS between January 2009 and December 2018 were retrospectively reviewed. Among them patients that have PITS/PTTS were recruted to the study. Patients who had tracheal stenosis due to the causes other than postintubation/ posttracheostomy and patients who had missing data were excluded from the study. Demographic characteristics, localization of the stenosis, stenosis lenght and degree, treatment techniques, post-procedural complications, and survival were recorded for all patients. The stenosis type was defined as complex, web-like, or mix. Degree of stenosis is classified into 3 groups: 1) mild stenosis (i.e. ≤ 50% reduction in the cross-sectional area (CSA), 2) moderate stenosis (51%-70% obstruction), 3) severe stenosis (≤ 71% reduction in CSA) (5) . The combination of interventions employed included mechanical dilatation, mechanical resection, cryio, argon plasma coagulation (APC), topical mitomycin-C application, bronchoscopic scissor and stent insertion.
All bronchoscopic procedures were performed either conscious sedation or IV-total anesthesia at the Division of Interventional Pulmonology of our hospital. While local anesthesia were used for flexible bronchoscopic procedures, IV-total anesthesia were used for rigid bronchoscopy. BF-1TQ180 or BF-XP160 (Olympus Medical Systems, Japan) with a 2.8 mm working channel were used for flexible procedures and Karl Storz, Germany for rigid ones. Conscious sedation is started with 2-5 mg midazolam and later on 10% lidocain sprey/gel was used for local anesthesia. During the procedure spray-as-you-go technique was applied with 1% lidocain solution. All patients were supported by either nasal or oral administration of oxygen and routine monitoring with pulse oximetry was done. IV-total anesthesia was achieved with 0.05-0.1 mg/kg midazolam, a maximum of 1 g propofol, a maximum of 2 mg remiphentanyl, and a maximum of 50 mg recuronium.
rESuLtS
A total of 110 patients between 2009 September-2018 Februrary were identified who had tracheal stenosis.
The mean age at time of entry into the study was 53.7 ± 16.7 (16-98 years) years. Of 110 patients, 54 (49.1%) were female. Most common comorbidity was hypertension while 17 patients had no comorbidity (Table 1) .
While trauma was the most seen cause of tracheal intubation (n= 20,18.1%), others were surgery (n= 10, 9.1%), or any kind of medical illness ( Table 2) . Twentynine (26.4%) patients had posttracheostomy stenosis, 81 of them (73.6%) had postintubation stenosis. Mean follow up period for all patients was 44.9 ± 32.3 month (range, 2-108 month). Most common type of stenosis was complex stenosis that occured in 82 (74.5%) patients, web-like stenosis was observed in 15 (13.63%), mix stenosis was observed in 13 (11.81%) patients. The mean lenght of stenosis was 2.1 ± 1.0 cm (range,1-6 cm). Mean distance from stenosis to vocal cord was 2.7 ± 0.8 cm (Table 3 ). Mean percentage of stenosis was 75.2 ± 15.2% (30-95%); 67 (60.9%) of them was severe stenosis, 31 (28.2%) of them was moderate stenosis, and 12 (10.9%) of them was mild stenosis.
All patients but one had mechanical dilatation as a therapeutic option. The median number of rigid bronhoscopy applied to all patients was 5 (min-max, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . Mechanical dilatation, APC, cryotherapy, and topical mitomycin-C application were therapeutic options for patients with web-like stenosis, mechanical dilatation, cryotherapy, and bronchoscopic scissor were therapeutic options for patients with complex, and mix stenosis. Cut with bronchoscopic scissor applied to 22 (20%) patients, 20 (18.2%) patients had cryotherapy, and 5 (4.5%) had APC application. We applied topical mitomycin-C to 6 (5.4%) of 110 patients. Tracheal stent insertion applied to 49 (44.5%) patients ( .0 (7-180) days. Most seen stenosis type was complex (n= 8) in these patients. Mean lenght of stenosis was 2 ± 0.9 cm, and percentage of stenosis was 62.9 ± 18.0. Of 12 patients with restenosis; 5 had tracheal stent insertion, 7 had mechanical dilatation, and 2 had cryotherapy (1 patient had both cryotherapy, and mechanical dilatation, 1 patient had both tracheal stent insertion, and mechanical dilatation) (Figure 1 ).
DISCuSSION
In this study, we evaluated the data of 110 patients with tracheal stenosis. We observed that the most seen cause of tracheal intubation was trauma (n= 20,18.1%), and most common type of stenosis was complex stenosis that occured in 82 (74.5%) patients.
The most applied therapeutic option was mechanical dilatation, other therapeutic modalities were; cut with scissors, cryotherapy, APC application, topical mitomycin-C, and tracheal stent insertion. During fol- One classification of tracheal stenosis was simple and complex. Simple ones are defined as the ones that are associated with a stenotic segment less than 1 cm in length with no associated tracheomalacia or loss of cartilaginous support (6) . Most common type of stenosis in our patients was complex stenosis that occured in 82 patients (74.5%).
The most diagnostic tools for PITS are rigid and flexible bronchoscopy. The gold standart approach for PITS assessment and management is rigid broncoscopy. Additionally, rigid bronchoscopy gives the chance of emergency dilatation and maintaning airway patency to the interventional bronchoscopist. Careful evaluation to determine the length and grade of stenosis and the peritracheal anatomic relationship is important. To assess these conditions flexible bronchoscopy is the preferred technique. Rigid with/without flexible fibereoptic bronchoscopy was performed to all of our cases.
The gold standard of PITS treatment is surgical reconstruction (7) . While there is no consencus for the ideal time of surgical treatment, some investigators recommend to perform when endoscopic procedures fail following one or several attempts (8, 9) . In our study, 36 of 110 patients had surgery, of these patients 19 had only 1 endoscopic attempt, other had more than one endoscopic procedures.
The outcomes of surgery were reported as good or satisfactory results in 93.7% of patients, failure in 3.9%, and a mortality rate of 2.4% (10) . In another study, the surgical success rate was as low as 61.5% George et al. reported 100 % success rate with surgery in their series of 26 adult patients with LTS (11, 12) . While mean resection length was 3.4 cm in their series, they also concluded that maximum 6 cm resection lenght was also feasible. Marulli et al. reported 28 LTS patients treated with anastomosis following surgical resection (13) . Mean resection lenght was 2.5 cm (ranging between 1.5 to 5.1 cm). In our study the mean resection lenght was 3.3 ± 1.3 (ranging between 1.7-6.2) cm. Our success rate (47.2%) was lower than the reported literatures. It may be due to our institution experience or our patients characteristics, they were older (their mean age was 48.05), in Abbasidezfouli' study mean age was 23.9 (11) .
Endoscopic procedures are accepted as alternative therapy to surgery, before twenty years it was shown that, silicone tracheobronchial stents were effective in the maintenance of airway patency and were associated with good tolerance (14) . In their study, Zias et al. stated that patients with comorbidities and poor performance status might not be eligible for surgery (15) . In the same study they reported that 95% of patients had severe tracheal stenosis that was exceeding 70%. Their preffered treatment options were Nd: YAG laser incision and either mechanical or baloon dilatation under rigid bronchoscopy.
Stenotic lesions which are approprate for endoscopic treatment have some key features: (a) the presence of an external cartilaginous support (b) short (les than 1 cm ) vertical stenotic length (for endoscopic stenting less than < 3 cm is preferable), (c) noncircumferential stenosis, and (d) strictly tracheal localization (16) . Moreover, endoscopic procedures can be used as a first line option up to definitive surgical intervention in patients who had simple stenosis. Recent developments in the field of interventional pulmonology led minimally invasive endoscopic approaches more popular in the management of PITS (17, 18) . Mostly used endoscopic interventions are mechanical or balloon dilation, laser incission, cryoextraction, electrocautery, photodynamic therapy, stenting, and local applications of mitomycin C, 5-fluorouracil, and steroids. Although rigid bronchoscopic techniques are commonly preferrred for endotracheal intervention, flexible bronchoscopy can also be used instead of rigid ones for intubation, dilatation, and stenting in patients with tracheal stenosis (19) .
However dilation procedures are safe and well-tolerated among patients, it is associated with temporary improvement and often requires repeated dilations or finally airway surgery. We performed mechanical dilation to 109 patients, but we had to repeat the procedure. The number of rigid bronhoscopy was 2.6 ± 2.6 (range, 1-19) for our patients. To overcome the high recurrence rates of dilatation, more efficient endoscopic techniques are developed. Among them, topical MMC application was approved as a procedure that might improve airway surgery outcomes (20) . It is a kind of anthracycline antibiotic that derived from Streptomyces caepitocus. MMC is an alkylating agent that inhibits DNA synthesis (21) . Smith and Elstad concluded that MMC may extend the time to recurrence in the majority of patients, but does not reduces the risk of recurrence (22) . On the other hand, there is data regarding the ineffectivity of MMC in the prevention of tracheal stenosis after rigid bronchoscopic dilatation in PITS patients (23) . In a study conducted by Madan et al. almost all patients experienced recurrence after a single dose of MMC application (0.4 mg/mL). In the English literature, a dose of 0.1-2 mg/mL MMC have been used (24, 25) . But the scarce data and poor trial quality in human studies makes it difficult to draw exact conclusions.
In our study, we applied MMC by using saturated pledgets at 0.5 mg/mL for 2 minutes over each stenosis site to 6 patients, 5 of them cured without any other procedure, 1 of them had tracheal stent application.
There is a wealth of literature supporting the use of tracheal stents in treating benign and malignant tracheal stenosis. Four (13.3%) patients in Elsayed et al's series went on to have tracheal stents after multiple failed dilations (26) . The use of metallic stents in malignant stenosis is well established but treatment of benign stenosis using metalic stents is contrendicated.
In their study, Martinez-Ballarin et al. reported their data regarding the use of silicone Dumon ® stents for tracheal stenting in a total of 64 patients who had inflammatory benign tracheal stenosis (14) . While the procedure was well-tolerated it was also associated with same complications such as stent migration (17.5%), granulation (6.3%) and airway obstruction due to mucostasis (6.3% The most encountered complications of surgery are excessive granulation and restenosis at the anastomosis line, fistula formation, cervicomediastinal sepsis, innominate artery rupture, anastomosis opening, and recurrent laryngeal nerve injury (29) . Alvarez-Maldonado et al. reported the incidence of restenosis after surgery 43% (3/7) (30). In our case series, 13 of 36 patients had restenosis after surgery, but we were not able to analyze factors related to its appearance.
The limitations of our study are; 1) It has a retrospective design, 2) Patients number is small in different therapy groups, so we were not able to compare these therapeutic options, 3) We were not able to analyze factors related to restenosis after surgery, 4) We were not able to compare the mortality rates between groups, and the causes of mortality, because of the retrospective design of the study. We could not reach all the information about the patients, and procedures. Future studies, which will investigate the most useful therapeutic option in PITS patients, will be able to add more information to the literature.
In conclusion, PITS/PTTS is an iatrogenic condition due to regional ischemic necrosis of the trachea. The recent developments and improvements in the design of endotracheal and tracheostomy tubes decreased the incidence of these conditions. However, it remains a major problem and a common indication for open tracheal surgery. Careful assessment of the degree and length of the lesion, presence of comorbidity are important when deciding treatment option.
